Table 4 Clinical study design and bioprinting-related items
From: Assessing the landscape of clinical and observational trials involving bioprinting: a scoping review
Trial ID/DOI | Study type | Phase | Application | Condition/s | Tissue type | Cell type/source | Bioink |
|---|---|---|---|---|---|---|---|
ChiCTR-IOR-16009658 | Interventional | N/A | Model | Ovarian Cancer | Tumor | Autologous tumor cells | Not specified |
NCT03832153 | Observational | N/A | Model | STEMI, Thrombi, MicroRNA | Not specified | Not specified | Not specified |
NCT03890614 | Observational | N/A | Model | Hematologic Malignancy | Tumor (organoid) | Autologous myeloma and stromal cells | Hyaluronic acid and gelatin-based hydrogel |
NCT04755907 | Observational | N/A | Model | Colorectal Cancer, Colorectal Cancer Liver Metastasis | Tumor (organoid) | Autologous tumor tissue | Not specified |
NCT04925323 | Interventional | N/A | Model | Plastic Surgeries | Skin | Autologous keratinocytes, fibroblasts | Not specified |
ChiCTR2200066886 | Interventional | 2 | Model | Pancreatic Cancer | Tumor (organoid) | Autologous tumor tissue | Not specified |
NCT05955092 | Observational | N/A | Model | Pancreatic Ductal Adenocarcinoma | Tumor | Autologous tumor tissue | Not specified |
NCT04399239 | Interventional | 1/2A | Implant | Microtia | Auricle | Autologous chondrocytes | Collagen hydrogel |
10.1177/15347346211045625 | Interventional | Unknown | Implant | Diabetic Foot Ulcer | Adipose | Autologous adipose tissue | Extracellular matrix |
ChiCTR2100049901 | Interventional | 0 | Implant | Peripheral Limb Arterial Disease | Blood vessel | Autologous stem cells | Not specified |
NCT06051747 | Interventional | 1/2 | Implant | Thyroid Cancer | Trachea | Autologous hNTSCs, hNCs | Hydrogel matrices |